z-logo
Premium
Interplay between cancer cells, macrophages and natural killer cells may actually decide the outcome of therapy with sorafenib
Author(s) -
Tomuleasa Ciprian,
Giannelli Gianluigi,
Cucuianu Andrei,
Aldea Mihaela,
Paradiso Angelo,
BerindanNeagoe Ioana
Publication year - 2014
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.26907
Subject(s) - sorafenib , tumor microenvironment , cancer research , cancer cell , cancer , metastasis , stromal cell , medicine , immunology , immune system , hepatocellular carcinoma

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom